Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D M Monroe

Showing results (71-80 of 83) with videos related to

Pageof 9
Sort By:
Biochemistry|May 16, 1998
Structure/function analyses of recombinant variants of human factor Xa: factor Xa incorporation into prothrombinase on the thrombin-activated platelet surface is not mimicked by synthetic phospholipid vesiclesP J Larson, R M Camire, D Wong, et al.
Thrombosis and Haemostasis|May 1, 1997
Extravascular administration of factor IX: potential for replacement therapy of canine and human hemophilia BD Liles, C N Landen, D M Monroe, et al.
Journal of Thrombosis and Haemostasis : JTH|April 16, 2013
Bleeding risk in warfarinized patients with a therapeutic international normalized ratio: the effect of low factor IX levelsY Dargaud, M Hoffman, L Lefrapper, et al.
Blood|May 1, 1989
Functional consequences of an arginine180 to glutamine mutation in factor IX HiloD M Monroe, D M McCord, M N Huang, et al.
Blood|March 1, 1990
Factor IX New London: substitution of proline for glutamine at position 50 causes severe hemophilia BJ N Lozier, D M Monroe, S Stanfield-Oakley, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 28, 2015
Coated platelet assay: a feasible approach to a complicated scienceB M Mohammed, D Contaifer, K K Lastrapes, et al.
The Journal of Biological Chemistry|February 16, 1996
Structural integrity of the gamma-carboxyglutamic acid domain of human blood coagulation factor IXa Is required for its binding to cofactor VIIIaP J Larson, S A Stanfield-Oakley, W J VanDusen, et al.
Blood|June 15, 1994
Severe factor VII deficiency caused by mutations abolishing the cleavage site for activation and altering binding to tissue factorS Chaing, B Clarke, S Sridhara, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|December 1, 1990
Calcium ion binding to human and bovine factor XD M Monroe, D W Deerfield, D L Olson, et al.
The Journal of Biological Chemistry|July 15, 1990
Molecular defect (Gla+14----Lys) and its functional consequences in a hereditary factor X deficiency (factor X "Vorarlberg")H H Watzke, K Lechner, H R Roberts, et al.
Pageof 9

Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
Biochemistry|May 16, 1998
Structure/function analyses of recombinant variants of human factor Xa: factor Xa incorporation into prothrombinase on the thrombin-activated platelet surface is not mimicked by synthetic phospholipid vesiclesP J Larson, R M Camire, D Wong, et al.
Thrombosis and Haemostasis|May 1, 1997
Extravascular administration of factor IX: potential for replacement therapy of canine and human hemophilia BD Liles, C N Landen, D M Monroe, et al.
Journal of Thrombosis and Haemostasis : JTH|April 16, 2013
Bleeding risk in warfarinized patients with a therapeutic international normalized ratio: the effect of low factor IX levelsY Dargaud, M Hoffman, L Lefrapper, et al.
Blood|May 1, 1989
Functional consequences of an arginine180 to glutamine mutation in factor IX HiloD M Monroe, D M McCord, M N Huang, et al.
Blood|March 1, 1990
Factor IX New London: substitution of proline for glutamine at position 50 causes severe hemophilia BJ N Lozier, D M Monroe, S Stanfield-Oakley, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 28, 2015
Coated platelet assay: a feasible approach to a complicated scienceB M Mohammed, D Contaifer, K K Lastrapes, et al.
The Journal of Biological Chemistry|February 16, 1996
Structural integrity of the gamma-carboxyglutamic acid domain of human blood coagulation factor IXa Is required for its binding to cofactor VIIIaP J Larson, S A Stanfield-Oakley, W J VanDusen, et al.
Blood|June 15, 1994
Severe factor VII deficiency caused by mutations abolishing the cleavage site for activation and altering binding to tissue factorS Chaing, B Clarke, S Sridhara, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|December 1, 1990
Calcium ion binding to human and bovine factor XD M Monroe, D W Deerfield, D L Olson, et al.
The Journal of Biological Chemistry|July 15, 1990
Molecular defect (Gla+14----Lys) and its functional consequences in a hereditary factor X deficiency (factor X "Vorarlberg")H H Watzke, K Lechner, H R Roberts, et al.
Pageof 9